Zhang, Mingcai
Du, Guoqing
Liu, Congying
Li, Wei
Yang, Jiayu
Chen, Bo
Yu, Xiaoyue
Xiong, Yizhe
Jiang, Enyu
Gao, Ningyang
Jiang, Sumin
Xu, Zhenqiu
Wang, Xiang
Zhan, Hongsheng
Funding for this research was provided by:
Shanghai top priority clinical key discipline construction project (2017ZZ02024)
National Natural Science Foundation of China (81704103)
Construction of Treatment Platform by Famous TCM Doctor Studio Team (ZY(2018-2020)-FWTX-6033)
Article History
Received: 26 July 2020
Accepted: 20 January 2021
First Online: 8 February 2021
Ethics approval and consent to participate
: The ethics of this trial research scheme was reviewed and approved by China registered clinical trial ethics review committee with approval number ChiECRCT20190068. After careful discussion and modification by the project team, the study plan of this project was registered on the website of the China Registered Clinical Trial Registration Center and further improved and modified according to the modification opinions provided by the expert team, with approval number ChiCTR1900021371. Each subject should voluntarily sign an informed consent form before testing begins in the study.
: Not applicable.
: The authors declare that they have no competing interests.